CASE STUDY
The Client:
A medical equipment manufacturing company producing specialized pharmaceutical and medical supply products requiring sophisticated cleanroom environments, precision filling equipment, and stringent quality control systems to meet FDA regulatory requirements and industry standards. Operating in the highly regulated healthcare manufacturing sector where facility design, equipment specifications, and process validation determine the ability to produce sterile medical products and pharmaceutical preparations, the business represented an ambitious start-up venture entering a capital-intensive industry with substantial barriers to entry. With innovative products and identified market opportunities, the company had developed a business plan requiring significant equipment investment in specialized assets including automated fillers, cleanroom construction, sterilization systems, and quality control instrumentation—equipment that would enable production at commercial scale but represented substantial upfront capital requirements before revenue generation could begin.
The Challenge:
When the medical equipment manufacturer approached First National Capital for funding, they faced the classic start-up dilemma amplified by industry-specific challenges that made traditional bank financing impossible. As a start-up company with no operating history or established revenue streams, the business lacked the financial statements and performance track record that conventional lenders require for equipment financing decisions. Traditional banks were particularly hesitant to fund the venture due to the highly specialized and unique nature of the equipment—including pharmaceutical fillers, cleanroom facilities, and specialized manufacturing systems with limited secondary market appeal and virtually no resale value outside the pharmaceutical and medical device manufacturing sectors. The high cost of manufacturing medical supplies and the regulatory compliance requirements meant that substantial capital deployment was necessary before the first product could be manufactured and sold, creating a timing mismatch between investment and revenue that traditional lenders avoid. The company needed a financing partner who would invest time to understand the pharmaceutical manufacturing business model, appreciate the strategic value of specialized equipment despite poor collateral characteristics, and provide flexible funding solutions structured to accommodate the realities of launching a regulated healthcare manufacturing operation.
Solution:
First National Capital recognized that innovative healthcare manufacturing ventures backed by experienced management teams deserve financing support even when start-up status and specialized equipment profiles fall outside traditional lending parameters. FNC worked closely with the company to understand their business needs, conducting deep diligence on the pharmaceutical manufacturing opportunity, regulatory pathway, market demand, and equipment requirements rather than simply declining based on lack of operating history. First National provided a customized leasing solution structured to accommodate the phased equipment deployment and facility build-out that pharmaceutical manufacturing requires, enabling the company to acquire critical assets as production capabilities expanded. Over multiple years as the business matured and scaled operations, First National Capital has financed over five lease schedules totaling $7 million, demonstrating sustained partnership through various growth phases rather than treating each equipment need as a standalone transaction requiring fresh underwriting. The ongoing relationship has been so successful that the company continues reaching out to open additional schedules and seeking more approval for 2023 leasing needs, confident that First National understands their business and will provide responsive capital solutions as expansion opportunities emerge. This multi-year partnership enabled a start-up medical equipment manufacturer to overcome the financing barriers that stop most early-stage healthcare ventures, deploy the specialized equipment necessary for FDA-compliant production, scale operations to meet market demand, and establish First National as the long-term financing partner supporting continued growth in the competitive pharmaceutical and medical supply manufacturing sector.
It All Begins With A Conversation
We listen. We live out-of-the-box. We solve problems. And we get deals done. Let’s do this.
